Zwerling C
Injury Prevention Research Center, College of Medicine, University of Iowa, Iowa City.
Bull Narc. 1993;45(2):155-96.
The present paper presents a review of the current practice and experience in drug and alcohol testing in the workplace, focusing primarily on the United States of America. After reviewing the history of workplace drug screening, the author describes the growth and impact of the drug-testing industry. He outlines the four most common rationales for workplace drug testing: safety, productivity, decreasing drug use and legislative/regulatory requirements. He summarizes the best studies on the prevalence of workplace drug testing in the United States and describes employer attitudes in that country. The author reviews in some detail the association between drugs, alcohol, occupational injuries and other adverse employment outcomes. He then reviews the literature on cost-benefit analysis of workplace drug testing. The author concludes that relatively little is known about the role of alcohol and drugs in the workplace. The important association between substance abuse and occupational injury has not been established. If there is such an association, it is much weaker than previously believed. The contradictory findings in different studies suggest that substance abuse may well play different roles in different occupational and cultural settings. Thus, caution should be exercised in transposing results from one setting to another. Finally, the review of cost-benefit analyses suggests that any economic analysis of workplace drug screening is likely to be greatly influenced by the prevalence of drugs in the population screened.
本文对职场中药物和酒精检测的当前实践与经验进行了综述,主要聚焦于美利坚合众国。在回顾了职场药物筛查的历史后,作者描述了药物检测行业的发展与影响。他概述了职场药物检测最常见的四个理由:安全、生产力、减少药物使用以及立法/监管要求。作者总结了关于美国职场药物检测普及率的最佳研究,并描述了该国雇主的态度。作者较为详细地回顾了药物、酒精、职业伤害及其他不良就业结果之间的关联。接着,他回顾了关于职场药物检测成本效益分析的文献。作者得出结论,对于酒精和药物在职场中的作用了解相对较少。药物滥用与职业伤害之间的重要关联尚未确立。即便存在这样的关联,其强度也远低于此前的认知。不同研究中的矛盾结果表明,药物滥用在不同的职业和文化环境中可能发挥不同的作用。因此,在将一种环境下的结果应用于另一种环境时应谨慎行事。最后,成本效益分析的综述表明,对职场药物筛查的任何经济分析很可能会受到所筛查人群中药物普及率的极大影响。